Among other statements, the American Association for the Study of Liver Diseases said that modifiable risk factors for bleeding, such as use of antithrombotic drugs, should be identified and corrected before procedures in patients with cirrhosis.
Patients with inflammatory bowel disease were diagnosed with dementia an average of seven years earlier than matched controls in a Taiwanese study.
Participation was higher and more colorectal cancer (CRC) and advanced adenomas were detected with repeated fecal immunochemical testing (FIT) compared to sigmoidoscopy, although the risks of perforation and bleeding were comparable.
A multicenter randomized trial in Japan found that a single surveillance colonoscopy three years postpolypectomy and two surveillance colonoscopies at one and three years were similarly accurate for detecting clinically important neoplastic lesions.
The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
Using clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score that was more transparent than a commonly used version of the Model for End-Stage Liver Disease, a study found.
While NSAIDs and a high consumption of fruits and vegetables were associated with a decreased incidence of colorectal cancer, frequent consumption of alcohol or meat was linked to increased colorectal cancer incidence, a systematic review found.
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
New evidence supports closer follow-up for some patients and less surveillance for others, according to a task force of the American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal
A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.